Abstract
Cyclodextrins, enzymatic degradation products of starch, emerge as promising biomaterials for the targeted delivery of anticancer drugs to tumor tissues. Once these molecules are chemically modified with aliphatic chains to render an amphiphilic property, they are able to form nanoparticles spontaneously without the help of surfactants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
